Semaglutide (Wegovy/Ozempic) trials showed 15% average weight loss, while tirzepatide (Mounjaro/Zepbound) trials showed up to 21% weight loss
W takiej sytuacji cena leku moe by o ok
At 52 weeks ( n = 54 comparisons, with evidence of inconsistency
Key takeaways Tirzepatide (sold as Mounjaro and Zepbound) is a once-weekly subcutaneous injection, typically administered into the abdomen, thigh, or upper arm
Tirzepatide is a dual-acting medication
For CY 2026, we proposed to apply for the CY 2026 OPPS wage index any adjustments for the FY 2026 IPPS post-reclassified wage index, including, but not limited to, the rural floor adjustment and a wage index floor of 1.00 in frontier states, in accordance with section 10324 of the Affordable Care Act of 2010